# Effect of Two Different Doses of Intrathecal Dexmedetomidine as Adjuvant in Elderly Patients Undergoing HoLEP

> **NCT05351489** · EARLY_PHASE1 · COMPLETED · sponsor: **Mansoura University** · enrollment: 70 (actual)

## Conditions studied

- Transurethral Resection of Prostate

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT05351489
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-30
- **Primary completion:** 2023-10-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05351489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05351489, "Effect of Two Different Doses of Intrathecal Dexmedetomidine as Adjuvant in Elderly Patients Undergoing HoLEP". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05351489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*